MET and ERBB2 are coexpressed in ERBB2+ breast cancer and contribute to innate resistance. [electronic resource]
Producer: 20140318Description: 1112-21 p. digitalISSN:- 1557-3125
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Proliferation
- Drug Resistance, Neoplasm
- ErbB Receptors -- metabolism
- Female
- Gene Expression Regulation, Neoplastic
- Gene Knockdown Techniques
- Humans
- MAP Kinase Signaling System
- Proto-Oncogene Proteins c-akt -- metabolism
- Proto-Oncogene Proteins c-met -- genetics
- Receptor, ErbB-2 -- antagonists & inhibitors
- Receptor, ErbB-3 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.